Savara Inc. (SVRA)
NASDAQ: SVRA · Real-Time Price · USD
4.840
-0.080 (-1.63%)
Oct 12, 2026, 4:00 PM EDT - Market closed
Savara Market Cap
Savara has a market cap or net worth of $1.23 billion as of October 12, 2026. It is the 9,093rd most valuable company in the world and the 2,109th biggest in the United States. Its market cap has increased by 111.16% in one year.
Market Cap
1.23B
Enterprise Value
1.09B
1-Year Change
111.16%
Global Rank
Country Rank
#2,109 United States
Category
ChartMarket Cap Chart
Since April 28, 2017, Savara's market cap has increased from $132.70M to $1.23B, an increase of 826.92%. That is a compound annual growth rate of 26.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 994.40M | -18.95% |
| Dec 31, 2025 | 1.23B | 132.85% |
| Dec 31, 2024 | 526.90M | -17.17% |
| Dec 29, 2023 | 636.10M | 259.79% |
| Dec 30, 2022 | 176.80M | 25.21% |
| Dec 31, 2021 | 141.20M | 126.65% |
| Dec 31, 2020 | 62.30M | -66.25% |
| Dec 31, 2019 | 184.60M | -30.58% |
| Dec 31, 2018 | 265.90M | -41.25% |
| Dec 29, 2017 | 452.60M | 241.07% |
| Apr 28, 2017 | 132.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tyra Biosciences | 1.37B |
| Alpha Tau Medical | 1.33B |
| Ascentage Pharma Group International | 1.32B |
| Damora Therapeutics | 1.30B |
| Replimune Group | 1.26B |
| ORIC Pharmaceuticals | 1.24B |
| Nanobiotix | 1.21B |
| LB Pharmaceuticals | 1.20B |